Drug intelligence / Profile preview

amoxicillin + clavulanate + clarithromycin

Development stage
Unknown
Lead developer
US Antibiotics
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination therapy** consisting of three drugs: **amoxicillin**, **clavulanate** (as clavulanic acid), and **clarithromycin**. - **Amoxicillin** is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. - **Clavulanate** acts as a beta-lactamase inhibitor, protecting amoxicillin from enzymatic degradation and thereby broadening its spectrum against beta-lactamase producing organisms. - **Clarithromycin** is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This combination does not correspond to a common branded product, but the pairing of amoxicillin and clarithromycin (often with other agents such as a proton pump inhibitor) is used for the eradication of **Helicobacter pylori** infection. Clavulanate is sometimes added to amoxicillin to extend its activity spectrum. The triple combination has also shown synergistic in vitro bactericidal activity against organisms like *Mycobacterium ulcerans*, and has been explored for severe or resistant infections where broad-spectrum and dual-mechanism coverage is necessary[2][4].

02

Targets

PBP (Penicillin-binding protein family)Bacterial 50S ribosomal subunitβ-lactamase

Beyond the preview

Go deeper on amoxicillin + clavulanate + clarithromycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin + clavulanate + clarithromycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call